[12/08/2008] Striving to advance the field of cardiac safety, the THEW initiative is developed for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, University of Rochester (UR), and other public and private stakeholders. The THEW is led by individuals from the UR, the Commissioner Office of the FDA, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health. More...

[05/27/2008] Dr. Janet Woodcock (Director, CDER-FDA) and Dr. Norman Stockbridge (Acting Director for the Division of Cardiovascular and Renal Products, CDER-FDA) signed a Letter of Agreement officially starting the partnership between the FDA and University of Rochester for the THEW initiative. More...

• Second THEW-Meeting, FDA Headquarter, Silver Spring, MD
• CSRC/HESI, Washington DC
• DIA Cardiac Safety, Spain
• ESCGO-Parma, Italy